On October 24, 2022 Myovant Sciences (NYSE: MYOV) ("Myovant") reported the cancellation of its earnings conference call for the quarter ended September 30, 2022 that had originally been scheduled for October 26, 2022 at 5:00 p.m. Eastern Time (Press release, Myovant Sciences, OCT 24, 2022, https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-cancels-second-quarter-earnings-conference-call [SID1234622332]). The call is being cancelled due to the announcement of the pending merger with Sumitovant Biopharma Ltd.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!